Accessibility setting


Select language

Skip to secondary menu

Skip to content

Jehovah’s Witnesses


Orthopedic Surgery

Management and Optimization of Hemostasis

The efficacy of combined use of intraarticular and intravenous tranexamic acid on reducing blood loss and transfusion rate in total knee arthroplasty.

Lin SY, Chen CH, Fu YC, Huang PJ, Chang JK, Huang HT.

Source‎: J Arthroplasty 2015;30(5):776-80.

Indexed‎: PubMed 25534864

DOI‎: 10.1016/j.arth.2014.12.001

Intraoperative pharmacotherapeutic blood management strategies in total knee arthroplasty.

Banerjee S, Issa K, Pivec R, McElroy MJ, Khanuja HS, Harwin SF, Mont MA.

Source‎: J Knee Surg 2013;26(6):379-86.

Indexed‎: PubMed 23955184

DOI‎: 10.1055/s-0033-1353992

Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty.

Iwai T, Tsuji S, Tomita T, Sugamoto K, Hideki Y, Hamada M.

Source‎: Int Orthop 2013;37(3):441-5.

Indexed‎: PubMed 23371424

DOI‎: 10.1007/s00264-013-1787-7

Hemostatic techniques reduce hospital stay following multilevel posterior cervical spine surgery.

Cho SK, Yi JS, Park MS, Hu G, Zebala LP, Pahys JM, Kang MM, Lee DH, Riew KD.

Source‎: J Bone Joint Surg Am 2012;94(21):1952-8.

Indexed‎: PubMed 23138237

DOI‎: 10.2106/JBJS.K.00632

Use of aortic balloon occlusion to decrease blood loss during sacral tumor resection.

Tang X, Guo W, Yang R, Tang S, Dong S.

Source‎: J Bone Joint Surg Am 2010;92(8):1747-53.

Indexed‎: PubMed 20660238

DOI‎: 10.2106/JBJS.I.01333

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use.

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Source‎: Ann Surg 2010;251(2):217-28.

Indexed‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

The use of recombinant factor VIIa for severe intractable bleeding during spine surgery.

Kaw LL Jr, Coimbra R, Potenza BM, Garfin SR, Hoyt DB.

Source‎: Spine 2004;29(12):1384-7.

Indexed‎: PubMed 15187645

The medical section of is designed as an informational resource primarily for use by clinicians and other health-care professionals. It provides neither medical advice nor treatment recommendations and does not substitute for an appropriately qualified health-care provider. The clinical literature cited is not published by Jehovah’s Witnesses, but it outlines transfusion-alternative strategies that might be considered. It is the responsibility of each qualified health-care provider to maintain awareness of new information, discuss options for care, and assist patients in making choices in accord with their medical condition, wishes, values, and beliefs. Not all listed strategies are appropriate or acceptable to all patients.

Patients: Always seek the advice of your doctor or other qualified health-care provider regarding medical conditions or treatments. Check with a doctor if you suspect you are ill.

The use of this website is governed by its terms of use.